» Articles » PMID: 14602439

Hypoxaemia in Sickle Cell Disease: Biomarker Modulation and Relevance to Pathophysiology

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2003 Nov 7
PMID 14602439
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Nocturnal oxyhaemoglobin desaturation might have a role in CNS complications related to sickle cell disease, and rates of painful crises. We attempted to examine the biological relations, and describe the haematological risk factors for oxyhaemoglobin desaturation.

Methods: The study population included children with sickle cell disease and controls. Cellular activation was assessed by measurement of soluble vascular cell adhesion molecule 1, P-selectin, L-selectin, and leukotriene B4. Erythrocyte-endothelial adhesion and routine haematological variables were assessed. Oxygen saturation (SaO2) was measured by pulse oximetry while children were awake and asleep. Children with a mean sleeping SaO2 of < or =93% were identified as hypoxaemic. Children were divided into four groups: controls (ten children), HbSC (nine, all normoxic), HbSS normoxic (13), and HbSS hypoxaemic (15).

Findings: Among haematological variables, sleeping SaO2 correlated only with packed-cell volume (r=0.7; p<0.0001). Inverse relations were noted between sleeping SaO2 and adhesion (-0.45; p<0.01), and markers of white-cell (-0.51; p<0.01), platelet (-0.61; p<0.001), and endothelial activation (-0.46; p<0.01). In the HbSS group who had sleeping hypoxaemia, waking SaO2 measurements showed continuing hypoxaemia, with similar correlation between SaO2 and cell activation markers.

Interpretation: Our adhesion-related findings suggest a potential mechanism for the increased occurrence of clinical vaso-occlusive crises in individuals with sickle cell disease who have oxyhaemoglobin desaturation. Release of cellular mediators in hypoxaemia, and the relation between anaemia and oxyhaemoglobin desaturation, suggest that risk factors for stroke, including anaemia, might have a role in CNS-vasculopathy through hypoxia-mediated pathways. Further more, hypoxaemia in the older child also occurs during the day; such mild untreated hypoxia could lead to an increased risk of vaso-occlusive episodes.

Citing Articles

Nocturnal hemoglobin desaturation in chronically transfused adults with sickle cell disease: a retrospective study.

Obadina M, Owens I, Chang A, Miller V, Little J J Sick Cell Dis. 2025; 2(1):yoaf003.

PMID: 40045981 PMC: 11878521. DOI: 10.1093/jscdis/yoaf003.


Global prevalence of elevated estimated pulmonary artery systolic pressure in clinically stable children and adults with sickle cell disease: A systematic review and meta-analysis.

Ghazaiean M, Darvishi-Khezri H, Najafi B, Karami H, Kosaryan M PLoS One. 2025; 20(2):e0318751.

PMID: 39946434 PMC: 11825009. DOI: 10.1371/journal.pone.0318751.


Protocol for a multicentric, double-blind, randomised controlled trial of hyperbaric oxygen therapy (HBOT) versus sham for treating vaso-occlusive crisis (VOC) in sickle cell disease (SCD) in patients aged 8 years or older (HBOT-SCD study).

Stirnemann J, Serratrice J, Mann T, Louge P, Christophe C, Samii K BMJ Open. 2024; 14(11):e084825.

PMID: 39613437 PMC: 11605825. DOI: 10.1136/bmjopen-2024-084825.


Role of endothelial dysfunction in sleep-disordered breathing in egyptian children with sickle cell disease.

Youssry I, Mostafa A, Hamed D, Hafez Y, Bishai I, Selim Y BMC Pediatr. 2024; 24(1):626.

PMID: 39354381 PMC: 11443814. DOI: 10.1186/s12887-024-05066-6.


Multicenter comparative study of polysomnography outcomes in children with the monogenic disorder sickle cell disease.

Alishlash A, Nourani A, Lebensburger J, Rothman J, Ali-Dinar T, Ezmigna D J Clin Sleep Med. 2024; 21(2):297-304.

PMID: 39347561 PMC: 11789244. DOI: 10.5664/jcsm.11372.